mTOR inhibition reduces cellular proliferation and sensitizes pituitary adenoma cells to ionizing radiation
MetadataShow full item record
AbstractBackground:: Pituitary adenomas are the most frequent brain tumor in adults. Although histologically benign, pituitary tumors cause significant morbidity and mortality. Neurosurgery and medical therapeutics may lessen the morbidity and mortality associated with pituitary tumors; however, these treatments are associated with significant adverse side effects. Thus, an improved understanding of pituitary adenomas at the molecular and cellular level is needed to design novel therapeutic compounds.
Methods:: To assess the effect of mammalian target of rapamycin (mTOR) inhibition on pituitary adenoma cells, rat GH3 or MMQ cells were treated with the clinically useful mTOR inhibitors, rapamycin or RAD001. Cellular proliferation and growth following exposure to mTOR inhibitors or radiation were assessed using biochemical methods.
Results:: In the present study, we observed basal activation of mTOR, downstream of constitutive Akt signaling, in rat GH3 adenoma cells. Functionally, the mTOR inhibitors, rapamycin and RAD001 (500 pMâ 5 nM), induced G1 growth arrest within 24 hours, an effect associated with reduced cellular proliferation. Both rapamycin and RAD001 decreased the phosphorylation of mTOR at the serine 2448, a key determinant of mTOR activity. Inhibition of mTOR also radiosensitized GH3 cells such that 2.5 Gy in combination with 500 pM rapamycin or RAD001 reduced cellular viability more effectively than 2.5 or 10 Gy alone.
Conclusions:: These data may support a possible therapeutic role for mTOR inhibitors in limiting the cellular proliferation and radioresistance of pituitary adenoma cells.
CitationSurg Neurol Int. 2011 Feb 23; 2:22
- Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro.
- Authors: Gorshtein A, Rubinfeld H, Kendler E, Theodoropoulou M, Cerovac V, Stalla GK, Cohen ZR, Hadani M, Shimon I
- Issue date: 2009 Sep
- Inhibition of PI3K/AKT/mTOR pathway enhances temozolomide-induced cytotoxicity in pituitary adenoma cell lines in vitro and xenografted pituitary adenoma in female nude mice.
- Authors: Dai C, Zhang B, Liu X, Ma S, Yang Y, Yao Y, Feng M, Bao X, Li G, Wang J, Guo K, Ma W, Xing B, Lian W, Xiao J, Cai F, Zhang H, Wang R
- Issue date: 2013 Mar
- Enhanced radiation damage of tumor vasculature by mTOR inhibitors.
- Authors: Shinohara ET, Cao C, Niermann K, Mu Y, Zeng F, Hallahan DE, Lu B
- Issue date: 2005 Aug 18
- Inhibition of NFkappaB reduces cellular viability in GH3 pituitary adenoma cells.
- Authors: Vender JR, Laird MD, Dhandapani KM
- Issue date: 2008 May
- Levels of p27 sensitize to dual PI3K/mTOR inhibition.
- Authors: Lee M, Theodoropoulou M, Graw J, Roncaroli F, Zatelli MC, Pellegata NS
- Issue date: 2011 Aug